13F filer · CIK 923093 ↗

Tudor Investment

You are looking at Q1 2017. See the latest, Q2 2026 →

Reported value

$3.25B

−16% on the quarter before

Positions

1,347

333 new · 341 sold out

Top 10

31.1%

of the value

Est. gain

+$58.5M

on stocks held all quarter

Est. return

+4.7%

on those stocks since Q4 2016

Filed

May 15, 2017

On SEC EDGAR ↗

Positions as of Mar 31, 2017, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.

SPDR S&P 500 ETF TrustPUT11%
SPDR S&P 500 ETF TrustCALL8.0%
Ishares Msci Emerging Markets - ETF2.2%
Nxp Semiconductors Nv1.9%
Time Warner Inc1.9%
Everbank Financial Corp1.5%
Syngenta-ADR1.4%
SPDR S&P 500 ETF Trust1.2%
Bioverativ Inc1.2%
Treehouse Food1.1%
Ipath S&P 500 Vix Short-Term Futures EtnPUT1.1%
Mead Johnson Nutrition Co-A1.1%
Vca Inc1.0%
Zimmer Biomet Holdings Inc1.0%
Davita Inc1.0%
Total System Services Inc.0.9%
United Healthcare Group0.8%
Cst Brands Inc0.8%
Fidelity National Information Services0.8%
Pacira Pharmaceuticals Inc0.7%
Mgm Resorts International0.7%
Bob Evans Farms Inc0.7%
Alibaba0.7%
Level 3 Communications Incorporated0.7%

Largest buys

Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Ishares Msci Emerging Markets - ETF~$72.8MNew · 0.0% → 2.2%+1,847,000 shares
  2. Bioverativ Inc~$38.4MNew · 0.0% → 1.2%+705,824 shares
  3. Vca Inc~$33.9MNew · 0.0% → 1.0%+370,000 shares
  4. Mead Johnson Nutrition Co-A~$33.3MAdded · 0.0% → 1.1%+373,391 shares
  5. Zimmer Biomet Holdings Inc~$31.4MAdded · 0.0% → 1.0%+257,450 shares
  6. Davita Inc~$31.4MNew · 0.0% → 1.0%+461,620 shares
  7. Treehouse Food~$28.0MAdded · 0.2% → 1.1%+331,092 shares
  8. Ipath S&P 500 Vix Short-Term Futures EtnPUT~$27.6MAdded · 0.3% → 1.1%+1,746,500 underlying
  9. Pacira Pharmaceuticals Inc~$22.9MNew · 0.0% → 0.7%+501,470 shares
  10. Bob Evans Farms Inc~$22.7MNew · 0.0% → 0.7%+350,000 shares

Largest sells

Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. SPDR S&P 500 ETF TrustPUT~$611.2MCut · 23.4% → 10.7%−2,592,700 underlying
  2. SPDR S&P 500 ETF Trust~$172.0MCut · 5.2% → 1.2%−729,685 shares
  3. SPDR S&P 500 ETF TrustCALL~$71.7MCut · 8.1% → 8.0%−304,000 underlying
  4. St Jude Med Inc (Stj)~$40.7MSold out · 1.0% → 0.0%−507,358 shares
  5. Danaher Corporation~$37.7MSold out · 1.0% → 0.0%−484,432 shares
  6. Mettler-Toledo International Inc~$35.6MCut · 0.8% → 0.0%−74,338 shares
  7. Endurance Specialty Holdings Ltd~$32.3MSold out · 0.8% → 0.0%−350,000 shares
  8. Whirlpool Corporation~$29.5MCut · 0.8% → 0.0%−172,062 shares
  9. Ishares Nasdaq Biotechnology ETF~$26.5MSold out · 0.7% → 0.0%−100,000 shares
  10. Time Warner IncCALL~$26.5MSold out · 0.7% → 0.0%−274,500 underlying

Holdings

As of Mar 31, 2017. Changes are in shares against Dec 31, 2016, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
SPDR S&P 500 ETF TrustPUTCOMMON STOCK · shares −64%10.7%$347.9M—
SPDR S&P 500 ETF TrustCALLCOMMON STOCK · shares −22%8.0%$258.8M—
Ishares Msci Emerging Markets - ETFCOMMON STOCK · shares New2.2%$72.8M—
Nxp Semiconductors NvCOMMON STOCK · shares +17% · price +5.6%1.9%$62.9M+$2.9M
Time Warner IncCOMMON STOCK · shares +12% · price +1.2%1.9%$60.5M+$649,258
Everbank Financial CorpCOMMON STOCK · shares −9.6% · price +0.2%1.5%$48.2M+$74,635
Syngenta-ADRCOMMON STOCK · shares +1.6% · price +12.0%1.4%$45.4M+$4.8M
SPDR S&P 500 ETF TrustCOMMON STOCK · shares −82% · price +5.5%1.2%$39.0M+$2.0M
Bioverativ IncCOMMON STOCK · shares New1.2%$38.4M—
Treehouse FoodCOMMON STOCK · shares +331% · price +17.3%1.1%$36.5M+$1.2M
Ipath S&P 500 Vix Short-Term Futures EtnPUTCOMMON STOCK · shares +336%1.1%$35.8M—
Mead Johnson Nutrition Co-ACOMMON STOCK · shares +2,387% · price +25.9%1.1%$34.7M+$286,643
Vca IncCOMMON STOCK · shares New1.0%$33.9M—
Zimmer Biomet Holdings IncCOMMON STOCK · shares +8,582% · price +18.2%0.98%$31.8M+$56,335
Davita IncCOMMON STOCK · shares New0.97%$31.4M—
Total System Services Inc.COMMON STOCK · shares +5.8% · price +9.0%0.87%$28.3M+$2.2M
United Healthcare GroupCOMMON STOCK · shares −16% · price +2.5%0.82%$26.7M+$645,924
Cst Brands IncCOMMON STOCK · shares −28% · price −0.1%0.79%$25.8M−$32,981
Fidelity National Information ServicesCOMMON STOCK · shares −17% · price +5.3%0.77%$25.0M+$1.3M
Pacira Pharmaceuticals IncCOMMON STOCK · shares New0.70%$22.9M—
Mgm Resorts InternationalCOMMON STOCK · shares +96% · price −5.0%0.70%$22.7M−$604,500
Bob Evans Farms IncCOMMON STOCK · shares New0.70%$22.7M—
AlibabaCOMMON STOCK · shares New0.69%$22.5M—
Level 3 Communications IncorporatedCOMMON STOCK · shares +21% · price +1.5%0.69%$22.4M+$278,301
Mobileye NvCOMMON STOCK · shares New0.67%$21.7M—
Total · 1,347 positions100%$3.25B+$58.5M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2016 to Q1 2017: 1,010 stocks held throughout, up $58.5M (+4.7%).

  1. Syngenta-ADR+$4.8M+12%
  2. Nxp Semiconductors Nv+$2.9M+6%
  3. Yahoo! Incorporated+$2.5M+20%
  4. Sherwin-Williams Company+$2.3M+15%
  5. Total System Services Inc.+$2.2M+9%
  6. Adeptus Health Inc-Class A−$368,505−76%
  7. Synchrony Financial−$426,967−5%
  8. Park Hotels & Resorts Inc−$528,639−14%
  9. Target Corporation−$530,013−24%
  10. Mgm Resorts International−$604,500−5%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$80.00B$40.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$71.91B+33%SEC ↗
Q1 2026$53.87B−0%SEC ↗
Q4 2025$54.03B−7%SEC ↗
Q3 2025$57.98B+26%SEC ↗
Q2 2025$45.92B+53%SEC ↗
Q1 2025$30.10B+15%SEC ↗
Q4 2024$26.28B−4%SEC ↗
Q3 2024$27.48B+41%SEC ↗
Q2 2024$19.52B+24%SEC ↗
Q1 2024$15.72B+27%SEC ↗
Q4 2023$12.42B+25%SEC ↗
Q3 2023$9.97B+19%SEC ↗
Q2 2023$8.38B+30%SEC ↗
Q1 2023$6.46B+28%SEC ↗
Q4 2022$5.06B+9%SEC ↗
Q3 2022$4.63B+22%SEC ↗
Q2 2022$3.81B−11%SEC ↗
Q1 2022$4.27B−29%SEC ↗
Q4 2021$5.98B−3%SEC ↗
Q3 2021$6.16B+16%SEC ↗
Q2 2021$5.29B+6%SEC ↗
Q1 2021$4.99B+41%SEC ↗
Q4 2020$3.54B+54%SEC ↗
Q3 2020$2.30B+14%SEC ↗
Q2 2020$2.02B+81%SEC ↗
Q1 2020$1.12B−50%SEC ↗
Q4 2019$2.23B−23%SEC ↗
Q3 2019$2.91B−17%SEC ↗
Q2 2019$3.51B+45%SEC ↗
Q1 2019$2.42B−52%SEC ↗
Q4 2018$5.06B+27%SEC ↗
Q3 2018$3.98B+38%SEC ↗
Q2 2018$2.87B−7%SEC ↗
Q1 2018$3.09B−22%SEC ↗
Q4 2017$3.94B+0%SEC ↗
Q3 2017$3.92B+19%SEC ↗
Q2 2017$3.28B+1%SEC ↗
Q1 2017$3.25B−16%SEC ↗
Q4 2016$3.88B−9%SEC ↗
Q3 2016$4.27B−10%SEC ↗
Q2 2016$4.72B+21%SEC ↗
Q1 2016$3.91BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.